At her March visit, a 68-year-old patient with hypertension and type 2 diabetes looked fine. Her blood pressure was a little high, but she said she’d been rushing to make the appointment. You adjusted nothing and scheduled her for July. In May, your inbox gets a discharge summary from the hospital across town: two nights for a hypertensive emergency, a new medication started by a hospitalist, and a follow-up instruction that nobody at your practice knew about until today.
For patients with chronic conditions, most of the year happens between visits. Your practice sees a handful of snapshots, a blood pressure on a Tuesday in March, an A1C in July, and fills in the rest with what patients remember to tell you. The cost of the gap is real, but it shows up in scattered places: an ED visit you hear about weeks later, a same-day slot that blows up a schedule, a quality measure missed at year-end, a patient who quietly decides urgent care is easier.
This article adds up the cost of not monitoring patients between visits from your practice’s side: clinical, operational, financial, and relational. It also gives you a way to estimate your own cost of inaction and a tiered approach to closing the gap that doesn’t assume every patient needs a device. It’s built from the between-visit programs Care VMA staff help run for independent practices.
The Patient Who Looked Stable at the Last Visit
A three-physician internal medicine practice in Georgia started tracking the hospital and ED notifications it received for its hypertension patients over six months. Most of the patients who appeared in those notifications had been seen in the office within the previous three months, and their last office readings were unremarkable or only mildly elevated. Several had home blood pressure cuffs. Nobody had asked them to send the readings anywhere.
None of this reflected poor care at the visits. The visits did what visits can do: capture a moment. The problem was the 12 weeks in between, when blood pressures drifted, medications ran out or were skipped, and nobody at the practice could see any of it until something forced the patient into the healthcare system somewhere else.
That’s the pattern behind most between-visit deterioration. The warning signs often exist. They just exist at the patient’s kitchen table, not in your chart.
What It Costs When Chronic Patients Aren’t Monitored Between Visits
What Between-Visit Monitoring Means
Between-visit monitoring is any structured way for a practice to see how a chronic patient is doing between scheduled appointments and to respond before a problem becomes urgent. It ranges from remote physiologic monitoring with connected devices, to monthly care management calls, to simple structured check-ins after a medication change. What makes it monitoring is that someone at the practice reviews what comes in and acts on it.
The Four Costs of the Silent Interval
When chronic patients go unmonitored between visits, the practice pays in four ways:
- Clinical cost: worsening trends, medication problems, and early warning signs go unseen until they become urgent.
- Operational cost: unplanned same-day visits, after-hours calls, and post-discharge scrambles disrupt schedules and staff.
- Financial cost: avoidable acute care counts against the practice in value-based arrangements, quality measures slip, and between-visit care that could be documented and billed isn’t.
- Relational cost: patients learn that the ED or urgent care is where they go between visits, and some stop coming back.
Why the Gap Stays Invisible to Most Practices
Three things keep the cost of the between-visit gap hidden.
First, visit-based care is built around snapshots. A blood pressure taken in the office after a rushed drive, a weight measured once a quarter, a patient’s memory of how their sugars have been: these are samples, and for patients whose conditions change week to week, the samples are too far apart to show a trend.
Second, the costs land in different places. The ED visit is billed by the hospital. The same-day slot looks like normal demand. The missed quality measure shows up in a report months later. The patient who leaves just doesn’t schedule again. No single report in your practice adds them up.
Third, nobody owns the interval. Physicians own the visit. Front desk staff own the schedule. Nurses and MAs own the phone queue. The weeks between visits belong to no one, so nothing in them gets reviewed unless the patient calls.
The Four Costs, in Practice Terms
The Clinical Cost: Trends Nobody Sees
Many chronic conditions give warning before they become emergencies, and the warning usually takes the form of a trend: blood pressures creeping up over several weeks, weight rising over a few days in a patient with heart failure, glucose readings drifting after a medication change, a patient who stops refilling a prescription.
A two-cardiologist practice we support reviewed its heart failure admissions over a year. In several cases, the patient’s own records, a bathroom scale, a notebook, later showed weight gain over the days before admission. The patients had been told to call if their weight went up. Some didn’t recognize the change as significant. Others called, reached voicemail after hours, and waited until morning. Those signals existed; there was just no structure to capture and act on them.
The Operational Cost: Unplanned Work
Unmonitored patients don’t stop needing care between visits. Their needs simply arrive unscheduled: same-day sick visits that push other patients back, refill requests that turn into clinical questions, after-hours calls, and post-discharge follow-ups that have to be squeezed in within days.
A family medicine practice we work with categorized its after-hours calls for a quarter. A large share came from patients with chronic conditions asking questions that a scheduled monthly check-in would have answered: medication side effects, home readings they weren’t sure about, symptoms that had been building for days. That’s work the practice was doing anyway, just at the most expensive and disruptive time.
The Financial Cost: Acute Care, Quality Measures, and Unclaimed Revenue
The financial cost depends on how your practice is paid, and most independent practices now carry some of each:
- In value-based and risk-bearing arrangements (Medicare Advantage quality programs, accountable care organizations, shared savings contracts), avoidable ED visits and admissions count against your attributed population’s cost, and uncontrolled chronic conditions show up directly in quality measures such as blood pressure and diabetes control.
- In fee-for-service, Medicare and many payers pay separately for between-visit work when it’s structured and documented: chronic care management, principal care management, remote physiologic monitoring, and remote therapeutic monitoring. Practices that provide informal between-visit care, phone calls, portal messages, medication adjustments, without that structure are doing the work and leaving the payment on the table.
- In both, an acute event often brings a cascade of follow-up work, some of it billable and much of it not.
An endocrinology practice we work with had most of its diabetes patients on quarterly visits. At year-end, its diabetes control measure for one Medicare Advantage contract fell short, largely because of patients whose A1C had drifted up between visits and who weren’t seen again in time to adjust treatment and recheck. The practice was already spending clinical time on many of those patients through phone calls and refill reviews. None of it was structured, and none of it was billed. Our guide to closing care gaps and HEDIS scores covers the quality-measure side in more depth.
The Relational Cost: Patients Who Learn to Go Elsewhere
Every time a chronic patient goes to urgent care or the ED for something your practice could have handled, they learn something about where to go next time. Some come back with records you never see. Some get started on medications that conflict with yours. Some decide they don’t need a primary physician at all. Patient loyalty in chronic care depends heavily on whether the practice is reachable and responsive between visits.
How to Close the Gap: A Tiered Monitoring Map
Not every chronic patient needs a connected device, and monitoring everyone the same way wastes staff time on stable patients while under-serving the ones at risk. We use a four-step approach.
Step 1: Estimate Your Own Cost of Inaction
Before choosing tools, put numbers on the gap using data you already have. For the last 12 months, pull:
- The number of patients with two or more chronic conditions, and how many have one higher-risk condition such as heart failure, uncontrolled hypertension, or poorly controlled diabetes.
- ED visits and hospital admissions for those patients, from your notifications, payer reports, or ACO data.
- Same-day and urgent visits by chronic patients.
- After-hours and nurse line calls from chronic patients.
- Your performance on chronic condition quality measures in each value-based contract.
- How many chronic patients received between-visit care that wasn’t billed: phone management, portal messages, medication adjustments.
You don’t need precise dollar values for each line. Seeing the counts side by side is usually enough to show where the gap is costing the most.
Step 2: Tier Your Chronic Panel by Risk
| Tier | Typical patients | Between-visit approach |
|---|---|---|
| Tier 1: High risk | Heart failure, uncontrolled hypertension, poorly controlled diabetes, recent hospitalization | Remote physiologic monitoring plus monthly care management, with clear escalation protocols |
| Tier 2: Moderate risk | Multiple chronic conditions, complex medication regimens, recent medication changes | Monthly chronic care management calls with targeted home readings |
| Tier 3: Single condition, generally stable | One chronic condition, controlled, with occasional changes | Principal care management or structured check-ins after visits and medication changes |
| Tier 4: Stable | Well-controlled, engaged patients | Standard visit schedule with reminders and easy access to the care team |
Tiers aren’t permanent. A patient moves up after a hospitalization or medication change and moves down after a stable stretch.
Step 3: Give Every Tier a Signal, an Owner, and a Response
Signal
Decide what information the practice will receive between visits for each tier: device readings, answers to a monthly call script, refill patterns, hospital and ED notifications, or patient-reported symptoms through a portal.
Owner
Name who reviews the signal and how often. This is where most programs succeed or fail. Signals with no owner are noise, and they create liability: the practice has data it isn’t acting on. For Tier 1 patients, this is the work Care VMA’s remote patient monitoring support takes on: reviewing device data daily, documenting it, and routing readings outside the practice’s thresholds to the nurse or physician under protocols they set.
Response
Write down what happens when a signal crosses a threshold: who is contacted, how quickly, and what the options are (a call, a medication adjustment by the physician, a same-day visit, or referral to urgent care). Physicians set the thresholds and the clinical responses. Non-clinical staff can own the routing, documentation, and follow-up.
Step 4: Start With One Tier and Measure
Start with Tier 1, a small number of high-risk patients with a clear protocol, and measure what changes: ED visits and admissions, same-day visits, after-hours calls, quality measures, and staff time. Expand once the workflow is stable. Our RPM workflow guide for clinics walks through the operational setup in detail.
Monitoring Mistakes That Add Risk Instead of Reducing It
Collecting Data Nobody Reviews
Sending patients home with devices before deciding who reviews the readings is the most common mistake. Unreviewed data creates both clinical risk and liability. The owner comes first, then the device.
Enrolling Everyone
Putting every chronic patient on the same program floods staff with readings from stable patients and dilutes attention for the ones at risk. Tier first.
Alert Thresholds Nobody Tuned
Default device thresholds tend to generate either too many alerts or too few. Set thresholds with your physicians by condition, review them after the first month, and adjust for individual patients when it makes clinical sense.
Monitoring Without Escalation Rights
If the person reviewing the signal can’t reach a clinician quickly or can’t get a patient a same-day slot, the program detects problems without being able to act on them. Build escalation paths and protected schedule capacity into the design.
Ignoring Patient Barriers
Some patients struggle with devices, connectivity, cost-sharing, or simply remembering to take readings. Ask about barriers at enrollment, offer simpler options (a phone call instead of an app), and expect some patients to do better with structured calls than with devices.
Advanced Between-Visit Strategy
Use the Signals You Already Receive
Many practices already receive hospital and ED notifications through payer portals, health information exchanges, or ACO feeds, and nobody reviews them in real time. Assigning someone to review those notifications every day and contact patients within a day or two of discharge is the cheapest between-visit signal available, and it often qualifies for transitional care management when the requirements are met.
The Value-Based Contract Lens
If your practice is in a shared savings arrangement or a Medicare Advantage quality program, look at your attributed chronic patients separately. That’s where avoidable acute care and missed quality measures hit hardest, and where between-visit monitoring has the clearest return. Start your Tier 1 enrollment there.
The Staffing Math
Between-visit monitoring takes staff time: enrolling patients, reviewing data, making calls, documenting, and escalating. The time required depends on the tier mix and the program, so measure it from your pilot rather than estimating. That time is the main practical barrier for small practices, and the reason many structure their programs with dedicated, non-clinical care management staff working under nurse and physician supervision. For practices running both programs, our guide to combining CCM and RPM explains how to share that staff time across them.
The Gap Between Visits Is Where Chronic Care Is Won or Lost
The cost of not monitoring patients between visits is real, but it’s scattered: ED visits you hear about late, unplanned work that disrupts the schedule, quality measures that slip, between-visit care your team already provides without structure or payment, and patients who learn to look elsewhere. Adding it up is the first step. Closing the gap means tiering your chronic panel, giving every tier a signal, an owner, and a response, and starting where the risk is highest.
There is an honest limit here. Monitoring doesn’t prevent every hospitalization, it takes real staff time, and some patients won’t engage no matter how the program is designed. A program that collects data without a clear owner and response protocol can do more harm than good. Physicians need to set the clinical rules, and the program needs to be measured against the costs it’s meant to reduce.
For many independent practices, the missing piece is the owner: someone whose job is the weeks between visits. That’s the role Care VMA’s virtual chronic care management staff fill: HIPAA-compliant team members who make the monthly calls, review the signals, document the work, and bring problems to your clinicians while they’re still small.
If you want to know what the gap is costing your practice, book a free consultation with the Care VMA team. We’ll help you estimate your own cost of inaction from your panel data and identify which patients to start with.
Frequently Asked Questions
What does it cost a practice when chronic patients aren’t monitored between visits?
The cost shows up in four places: clinical (worsening trends go unseen), operational (unplanned same-day visits and after-hours calls), financial (avoidable acute care in value-based contracts, missed quality measures, and between-visit work that isn’t billed), and relational (patients who turn to urgent care or the ED instead of the practice).
Which patients benefit most from between-visit monitoring?
Patients with conditions that can change quickly between visits, such as heart failure, uncontrolled hypertension, or poorly controlled diabetes, and patients with multiple chronic conditions, complex medications, or a recent hospitalization usually benefit most. Stable, well-controlled patients often need only their regular visits and easy access to the care team.
Is remote patient monitoring the only way to monitor patients between visits?
No. Remote physiologic monitoring suits high-risk patients with measurable signs, while monthly chronic care management calls, principal care management, structured check-ins after medication changes, and daily review of hospital and ED notifications cover many other patients.
How does between-visit monitoring affect value-based contracts?
In shared savings, ACO, and Medicare Advantage quality arrangements, avoidable ED visits and admissions raise the cost of care for your attributed patients, and uncontrolled conditions lower quality scores. Catching problems earlier can improve both, which is why many practices start monitoring with their attributed chronic patients.
How much staff time does between-visit monitoring take?
It depends on how many patients are enrolled, their risk tier, and the programs used. Practices should measure staff time during a small pilot before expanding. Many use dedicated care management staff working under nurse and physician supervision so clinicians aren’t absorbing the work.
How should a practice start monitoring patients between visits?
Estimate the cost of the gap from your own data, tier your chronic patients by risk, assign each tier a signal, an owner, and a response protocol, and start with a small group of high-risk patients. Measure results before expanding.
